DNTH - Dianthus Therapeutics Inc Qarzning balans kapitallashuviga nisbati
Dianthus Therapeutics (DNTH) immunologik tadqiqotlarga kiritilgan investitsiyalarga tayanadi, chunki hozirda barqaror pul oqimi mavjud emas va joriy ko'rsatkich 0.00 ni tashkil etadi. Kompaniyaning ekologik rivojlanish vektori antitanachlar sintezi paytida zararli emissiyalarni minimallashtirishga asoslangan. GURU.Markets dagi narxlar tarixi aktivning bozor tebranishlarini aniq namoyish etadi. Kirishning yuqori to'sig'i qat'iy tartibga soluvchi nazorat va noyob molekulalarni patentlar bilan himoya qilish zarurati tufayli yuzaga kelgan.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_DNTH_-_Dianthus-Therapeutics_-_Debt-to-Net-Assets-Ratio "Dianthus Therapeutics - DNTH Qarzning balans kapitallashuviga nisbati (davr: 21.02.2024 - 28.10.2026) | 👁️GURU.Markets👁️")
Dianthus Therapeutics Inc (DNTH) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Dianthus Therapeutics|DNTH - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Dianthus Pharma|DNTH - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Dianthus Corp|DNTH - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Dianthus Therapeutics
Kompaniyaning jamlanma tahliliyoti:Dianthus Therapeutics (DNTH)
Umumiy majburiyatlarning kapitalga nisbati emitentning kreditga layoqatliligini baholash, moliyaviy mustaqillik darajasini va defolt xavfini aniqlash uchun ishlatiladi. Qarz kapitalining kitob kapitalizatsiyasiga joriy nisbatini tahlil qilish orqali investor xavfsizlik va resurslar samaradorligi o'rtasidagi muvozanatni aniqlashi mumkin. Dianthus Therapeutics (DNTH) uchun ushbu metrikaning past qiymati DNTH-103 yirik miqyosli sinovlari uchun moliyalashtirishning ishonchliligini tasdiqlaydi va immunologiya nishasida kengayish davrida qarz yuklarini bartaraf etadi.
Dianthus Therapeutics kimlar bilan raqobatlashadi
Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|PHVS: Qarzning balans qiymatiga nisbati|ABCL (AbCellera Corp) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Tourmaline Bio Inc|PGEN (Intrexon) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PHAR|Qarzning balans kapitallashuviga nisbati Nektar Therapeutics NKTR|Qarzning balans qiymatiga nisbati upstreambio.com (UPB)|ZBIO: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Immunome Inc IMNM|Gossamer Corp (GOSS) - Balans kapitallashuviga qarzlar|KALV - Qarzning balans qiymatiga nisbati|Septerna Inc - Balans kapitallashuviga qarzlar|pieris.com (PVLA) - Sof aktivlarga qarzlar|SVRA (Savara) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar RIGL|Qarzning balans kapitallashuviga nisbati AnaptysBio Corp ANAB|Qarzning balans qiymatiga nisbati Astria Corp ATXS|Qarzning balans qiymatiga nisbati enGene Holdings Inc. (ENGN)|Qarzning balans kapitaliga nisbati RAPT Therapeutics Inc. RAPT|Balans kapitallashuviga qarzlar Aerovate (JBIO)|Aclaris Therapeutics Inc. (ACRS) - Qarzning sof aktivlarga nisbati|KYTX: Qarzning balans qiymatiga nisbati|TLSA (Tiziana Life Sciences, Ltd.) - Balans kapitallashuviga qarzlar|CABA: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar ventyxbio.com (VTYX)|Theratechnologies (THTX) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Avalo Therapeutics, Inc. AVTX|Qarzning balans qiymatiga nisbati Eledon (ELDN)|Qarzning balans kapitaliga nisbati Agenus, Inc AGEN|Balans kapitallashuviga qarzlar Climb Bio Inc (CLYM)|ZURA - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar ATYR|ADAG (Adagene Inc.) - Balans qiymatiga qarzlar|IMA - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Shattuck Therapeutics|Balans kapitallashuviga qarzlar EQ|Balans kapitallashuviga qarzlar CNTB (connectbiopharm.com)|Immunic (IMUX) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Atara Biotherapeutics, Inc. ATRA|IFRX (InflaRx GmbH) - Balans kapitallashuviga qarzlar|X4 Pharmaceuticals, Inc (XFOR) - Balans qiymatiga qarzlar|ACET: Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Celularity|INmune Bio (INMB) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati Barinthus Biotherapeutics PLC|KZR (Kezar Life Sciences, Inc) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar SAB Biotherapeutics Inc (SABS)|Akari Therapeutics - Balans kapitallashuviga qarzlar|Enlivex Therapeutics Ltd - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati QTTB (Q32 Bio Corp)|GOVX - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar Edesa|IBIO (iBio Corporation) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Carisma Therapeutics Inc (CARM)|Qarzning balans qiymatiga nisbati xtlbio.com (XTLB)|Qarzning balans qiymatiga nisbati Bolt Biotherapeutics|Qarzning balans kapitaliga nisbati hcwbiologics.com (HCWB)|Balans kapitallashuviga qarzlar Aptevo Therapeutics Inc.|AIM ImmunoTech, Inc. - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Aditxt Corp|GRI - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar XORTX Therapeutics XRTX|Vyome Holdings Inc. (HIND) - Qarzning sof aktivlarga nisbati|REVB (Revelation Bio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar INDP|Scinai Immunotherapeutics (SCNI) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati CALI (calcimedica.com)|Affimed N.V. - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Allakos Inc ALLK|HOOKIPA - Balans kapitallashuviga qarzlar|IGM Biosciences, Inc. (IGMS) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati iTeos Therapeutics ITOS|oceanbiomedical.com (OCEA) - Qarzning sof aktivlarga nisbati|TCBP: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar THRD